Clinical trial
Whole Body Physiologically Based Pharmacokinetic (PBPK) Model to Estimate Cerebral and Systemic Midazolam Concentrations in ICU Patients Under Sedation.
NCT01973894 is registered in ClinicalTrials.gov with Università degli Studi dell'Insubria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Whole Body Physiologically Based Pharmacokinetic (PBPK) Model to Estimate Cerebral and Systemic Midazolam Concentrations in ICU Patients Under Sedation.
- Lead sponsor
- Università degli Studi dell'Insubria
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- May 31, 2014
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coma, respiratory failure